{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Subject(ID=57117L,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/Subject(ID=57117L,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.Subject"},"Meetings":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Meeting(ID=4615L,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4615L,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.Meeting"},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4615L,Language='DE')/Sessions"}},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4615L,Language='DE')/Subjects"}},"ID":"4615","Language":"DE","MeetingNumber":5,"IdSession":5115,"SessionNumber":15,"SessionName":"Sommersession 2022","Council":1,"CouncilName":"Nationalrat","CouncilAbbreviation":"NR","Date":"\/Date(1654560000000)\/","Begin":"1430","Modified":"\/Date(1659690252097)\/","LegislativePeriodNumber":51,"PublicationStatus":"final","MeetingOrderText":"F\u00fcnfte Sitzung","SortOrder":5,"Location":"N"},"SubjectsBusiness":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20227355,IdSubject=57117L,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20227355,IdSubject=57117L,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.SubjectBusiness"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20227355,IdSubject=57117L,Language='DE')/Subjects"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20227355,IdSubject=57117L,Language='DE')/Businesses"}},"IdSubject":"57117","BusinessNumber":20227355,"Language":"DE","BusinessShortNumber":"22.7355","Title":"Tierarzneimittel (TAM) - Notstand in der Schweiz dank erschwertem Zulassungsverfahren (1)","SortOrder":1,"PublishedNotes":null,"Modified":"\/Date(1654346214653)\/","TitleDE":"Fragestunde.\nFrage Haab Martin.\nTierarzneimittel (TAM). Notstand\nin der Schweiz dank erschwertem\nZulassungsverfahren (1)","TitleFR":"Heure des questions.\nQuestion Haab Martin.\nM\u00e9dicaments v\u00e9t\u00e9rinaires.\nP\u00e9nurie en Suisse provoqu\u00e9e\npar une proc\u00e9dure d'autorisation\ntrop contraignante (1)","TitleIT":null}]},"Transcripts":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Transcript(ID=301495L,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=301495L,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.Transcript"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=301495L,Language='DE')/Subjects"}},"MembersCouncil":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=301495L,Language='DE')/MembersCouncil"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=301495L,Language='DE')/Businesses"}},"ID":"301495","Language":"DE","IdSubject":"57117","VoteId":null,"PersonNumber":1161,"Type":1,"Text":"<pd_text><p>Swissmedic stellt mit der Zulassung sicher, dass sichere und wirksame Arzneimittel auf den Markt kommen, und legt damit die Grundlage f\u00fcr eine leistungsf\u00e4hige Markt\u00fcberwachung. Im Zulassungsverfahren ber\u00fccksichtigt Swissmedic nach M\u00f6glichkeit die Entscheide von ausl\u00e4ndischen Beh\u00f6rden. Trotz des kleinen Marktes werden in der Schweiz im Vergleich zu den zentralen EU-Zulassungen die meisten neuen Tierarzneimittel zur Zulassung eingereicht und auch gutgeheissen. Generell kann es vorkommen, dass ein \u00e4lteres Arzneimittel durch ein vergleichbares neueres vom Markt verdr\u00e4ngt wird. Falls ein ben\u00f6tigtes Tierarzneimittel in der Schweiz nicht zugelassen ist, besteht f\u00fcr Medizinalpersonen die M\u00f6glichkeit, dieses aus dem Ausland zu importieren. Der Bundesrat sieht daher zurzeit keinen Handlungsbedarf. </p>\n</pd_text>","MeetingCouncilAbbreviation":"N","MeetingDate":"20220607","MeetingVerbalixOid":3558,"IdSession":"5115","SpeakerFirstName":"Alain","SpeakerLastName":"Berset","SpeakerFullName":"Berset Alain","SpeakerFunction":"VPBR-M","CouncilId":99,"CouncilName":"Bundesrat","CantonId":10,"CantonName":"Freiburg","CantonAbbreviation":"FR","ParlGroupName":null,"ParlGroupAbbreviation":null,"SortOrder":1,"Start":"\/Date(1654614991244)\/","End":"\/Date(1654615052474)\/","Function":"VPBR-M","DisplaySpeaker":true,"LanguageOfText":"DE","Modified":"\/Date(1774876946164)\/","StartTimeWithTimezone":"\/Date(1654614991243+0120)\/","EndTimeWithTimezone":"\/Date(1654615052473+0120)\/","VoteBusinessNumber":null,"VoteBusinessShortNumber":null,"VoteBusinessTitle":null}]},"ID":"57117","Language":"DE","IdMeeting":"4615","VerbalixOid":682537,"SortOrder":26,"Modified":"\/Date(1774876946157)\/"}}